Modafinil for the Treatment of Cocaine Dependence

National Institute on Drug Abuse (NIDA)6 sites in 1 country210 target enrollmentOctober 2004

ConditionsCocaine-Related Disorders

DrugsModafinil

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Cocaine-Related Disorders
Sponsor: National Institute on Drug Abuse (NIDA)
Enrollment: 210
Locations: 6
Primary Endpoint: Cocaine abstinence
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Detailed Description

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Registry

clinicaltrials.gov

Start Date

October 2004

End Date

December 2006

Last Updated

9 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

National Institute on Drug Abuse (NIDA)

Eligibility Criteria

Inclusion Criteria

•Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
•Must be seeking treatment for cocaine dependence.
•Must be able to understand and provide written informed consent.